Abbott India Ltd. (ABBOTINDIA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 919728, "name": "Abbott India", "stock_name": "Abbott India", "full_name": "Abbott India Ltd.", "name_url": "stocks-analysis/abbott-india", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "26,978.45", "chg": 154.8, "chgp": "0.58%", "dir": 1, "prev_price": "26,823.65", "mcapval": "57,327.32 Cr", "mcap": "Mid Cap", "scripcode": 500488, "symbol": "ABBOTINDIA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE358A01014", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "1.97 k", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbott-india-919728-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Abbott India Ltd. Rallies 5.41% and Approaches 50 DMA Resistance — A Key Technical Test Ahead", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-hits-intraday-high-with-541-surge-on-24-mar-2026-3910820", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_priceRelatedfactors_3910820.png", "date": "2026-03-24 15:01:02", "description": "The Sensex gained 1.95% on 24 Mar 2026, yet Abbott India Ltd. outperformed with a 5.41% surge, touching an intraday high of Rs 27,001.6. This 3.46-percentage-point outperformance signals a stock-specific strength amid a broader market that remains under pressure, raising the question of whether this rally marks a genuine recovery or a technical rebound within a mixed trend." }, { "title": "Markets Rally, But Abbott India Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-stock-falls-to-52-week-low-of-rs25350-3910168", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_priceRelatedfactors_3910168.png", "date": "2026-03-24 10:36:54", "description": "" }, { "title": "Abbott India Ltd: Valuation Shift Signals Caution Amid Price Correction", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-valuation-shift-signals-caution-amid-price-correction-3909074", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_valuationdot_3909074.png", "date": "2026-03-24 08:01:40", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This article delves into the implications of these changes, analysing key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to historical trends and peer benchmarks, while also considering the company’s recent market performance and sector context." }, { "title": "Abbott India Ltd. Falls to 52-Week Low of Rs 25,437 Amid Market Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-stock-falls-to-52-week-low-amid-market-downturn-3907853", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_priceRelatedfactors_3907853.png", "date": "2026-03-23 12:37:25", "description": "A sharp decline in Abbott India Ltd. shares has pushed the stock to a fresh 52-week low of Rs 25,437.45 on 23 Mar 2026, marking a significant underperformance relative to both its sector and the broader market indices." }, { "title": "Abbott India Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-3904862", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_mojoScore_3904862.png", "date": "2026-03-21 10:10:25", "description": "Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Abbott India Ltd Gains 3.21%: Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-gains-321-technical-momentum-shifts-amid-mixed-signals-3891544", "imagepath": "", "date": "2026-03-14 16:10:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Stock hits 52-week low near Rs.26,000</p>\n <p><strong>4 Mar:</strong> Sharp 3.69% intraday gain to Rs.27,818.15</p>\n <p><strong>5 Mar:</strong> MarketsMOJO upgrades rating to Hold</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.27,345.20 (+3.21% weekly)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26,827.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.27,345.20</div><div class=\"stat-change positive\">+3..." }, { "title": "Abbott India Ltd Falls 1.57%: Technical Weakness and Valuation Concerns Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-falls-157-technical-weakness-and-valuation-concerns-shape-the-week-3891029", "imagepath": "", "date": "2026-03-14 12:07:22", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>9 Mar:</strong> Technical momentum shifts to bearish, stock closes at Rs.27,158.55 (-0.68%)</p>\n <p><strong>10 Mar:</strong> Downgrade to Sell rating announced, stock falls further to Rs.26,903.60 (-0.94%)</p>\n <p><strong>11 Mar:</strong> Price rebounds to Rs.27,211.05 (+1.14%) amid mixed market sentiment</p>\n <p><strong>12 Mar:</strong> Sharp decline to Rs.26,695.20 (-1.90%) as bearish signals persist</p>\n <p><strong>13 Mar:</strong> Week closes at Rs.26,916.10 (+0.83%) with Sensex down 2.29%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><di..." }, { "title": "Abbott India Ltd. Downgraded to Sell Amid Technical Weakness and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3882116", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_mojoScore_3882116.png", "date": "2026-03-10 08:21:24", "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 9 March 2026. This shift reflects a combination of deteriorating technical indicators, flat financial performance, and valuation pressures despite the company’s strong long-term fundamentals. The downgrade comes amid a challenging market environment and signals caution for investors considering exposure to this mid-cap pharmaceutical stock." }, { "title": "Abbott India Ltd. Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-bearish-signals-3879016", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AbbottIndiaLtd_technicaldot_3879016.png", "date": "2026-03-09 08:01:36", "description": "Abbott India Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling caution for investors amid a challenging market backdrop." } ], "total": 217, "sid": "919728", "stock_news_url": "https://www.marketsmojo.com/news/abbott-india-919728" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "27-Feb-2026", "details": "Abbott partners with Novo Nordisk India to launch Extensior broadening access to Semaglutide (Ozempic) for advanced diabetes management.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "18-Feb-2026", "details": "Voting Results along with the Consolidated Scrutinizers Report.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "13-Feb-2026", "details": "Newspaper Publication of the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Abbott India Ltd. has declared <strong>4750%</strong> dividend, ex-date: 25 Jul 25", "dt": "2025-07-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Stock hits 52-week low near Rs.26,000

4 Mar: Sharp 3.69% intraday gain to Rs.27,818.15

5 Mar: MarketsMOJO upgrades rating to Hold

6 Mar: Week closes at Rs.27,345.20 (+3.21% weekly)

Read full news article

Abbott India Ltd Falls 1.57%: Technical Weakness and Valuation Concerns Shape the Week

2026-03-14 12:07:22

Key Events This Week

9 Mar: Technical momentum shifts to bearish, stock closes at Rs.27,158.55 (-0.68%)

10 Mar: Downgrade to Sell rating announced, stock falls further to Rs.26,903.60 (-0.94%)

11 Mar: Price rebounds to Rs.27,211.05 (+1.14%) amid mixed market sentiment

12 Mar: Sharp decline to Rs.26,695.20 (-1.90%) as bearish signals persist

13 Mar: Week closes at Rs.26,916.10 (+0.83%) with Sensex down 2.29%

Read full news article

Abbott India Ltd. Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-03-10 08:21:24

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 9 March 2026. This shift reflects a combination of deteriorating technical indicators, flat financial performance, and valuation pressures despite the company’s strong long-term fundamentals. The downgrade comes amid a challenging market environment and signals caution for investors considering exposure to this mid-cap pharmaceutical stock.

Read full news article

Abbott India Ltd. Technical Momentum Shifts Amid Bearish Signals

2026-03-09 08:01:36

Abbott India Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling caution for investors amid a challenging market backdrop.

Read full news article

View All News